KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Gross Profit: 2013-2015

Historic Gross Profit for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Sep 2015 value amounting to $9.6 million.

  • Biocryst Pharmaceuticals' Gross Profit was N/A to $9.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $43.1 million, marking a year-over-year change of. This contributed to the annual value of $13.5 million for FY2014, which is 21.74% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Gross Profit of $9.6 million as of Q3 2015, which was down 54.81% from $21.3 million recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Gross Profit peaked at $21.3 million during Q2 2015, and registered a low of $744,000 during Q2 2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Gross Profit had a median value of $6.1 million in 2014 and averaged $7.4 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Gross Profit slumped by 48.79% in 2014 and then skyrocketed by 1,360.30% in 2015.
  • Biocryst Pharmaceuticals' Gross Profit (Quarterly) stood at $10.6 million in 2013, then plummeted by 48.79% to $5.4 million in 2014, then skyrocketed by 1,360.30% to $9.6 million in 2015.
  • Its last three reported values are $9.6 million in Q3 2015, $21.3 million for Q2 2015, and $6.8 million during Q1 2015.